Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on July 11.

Entresto API is expected to be the largest product in Divi’s Laboratories’ innovator Custom Synthesis (CS) portfolio.

Shares of Glenmark Pharma are in F&O ban on Monday, July 14, which means no new positions can be created in the stock.

Sensex Today | Stock Market LIVE Updates: The Q1 earnings season has not taken off the way it should have, with both TCS and Tata…

Global benchmark Brent was little changed above $70 a barrel, after gaining 3% last week, while West Texas Intermediate was above $68.

US Stock Market Live: Futures on Wall Street are continuing from where they left off on Friday, as profit booking continued from higher levels amidst…

Close to 50 companies will be having their record dates on Friday, July 18. Apart from those, other names like Samvardhana Motherson, Motherson Sumi Wiring,…

India’s Mutual Funds had a 13.86% stake in Paytm as of June 30, higher than the 13.11% they owned in March. Mirae Asset MF (3.2%),…

Purchasers will have the right of first offer followed by a right of first refusal in the event the promoter entities and Dilip Piramal intend…

Drug major Cipla, led by MD and CEO Umang Vohra, is entering India’s weight management segment and strengthening its CNS therapeutic area.